Eli Lilly’s drug lebrikizumab has been approved for the treatment of eczema, or atopic dermatitis, a win for the company after the FDA rejected the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Women diagnosed with perinatal depression are more likely to develop cardiovascular disease in the following 20 years compared to women who have given birth without
Apogee Therapeutics launched last year with $169 million in private financing and is headed for an IPO. The startup was spun out of Paragon Therapeutics
As the fifth major pharma player to stake a claim in radiopharmaceuticals, AstraZeneca sees big potential in improving on current options and exploring combination cancer